Current etf page

ETF Analytics

IHI ETF Holdings & Fundamentals

Fund Profile · Cost · Size · Liquidity · Exposure

Financial ServicesAsset ManagementScore data as of Oct 30, 2026

IHIiShares U.S. Medical Devices ETF

Financial Services / Asset Management

Low Priority

Above Peers

NeutralEdge 6/10
$54.59−$1.10 (−1.98%)

Latest quote

  • Momentum
    79
  • Value
    31
  • Quality
    59
  • Risk resilience
    70
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

IHI Holdings

49 holdings; the ten largest make up 74.18% of the fund. Holdings as of Sep 11, 2026.

Holdings
49
Top 10 weight
74.18%
Share of the fund in its ten largest positions
Largest holding
ABT
18.88%
Expense ratio
0.37%
$37.00 a year per $10,000
Fund size
$3.66B
Top 25 holdings by weight
RankSymbolHoldingWeightMarket value
1ABTABBOTT LABORATORIES18.88%$611.51M
2ISRGINTUITIVE SURGICAL12.88%$417.39M
3SYKSTRYKER9.79%$317M
4BDXABECTON DICKINSON5.28%$171.18M
50Y6X.LMEDTRONIC PLC4.97%$161.11M
6DXCMDEXCOM INC4.82%$156.1M
7RMDRESMED4.75%$153.87M
8GEHCGE HEALTHCARE TECHNOLOGIES4.41%$142.98M
9EWEDWARDS LIFESCIENCES4.35%$141.03M
10BSXBOSTON SCIENTIFIC CORP4.04%$130.86M
11IDXXIDEXX LABORATORIES4.02%$130.15M
12STESTERIS3.14%$101.74M
13ZBHZIMMER BIOMET HOLDINGS2.73%$88.27M
14BAXBAXTER INTERNATIONAL1.88%$60.75M
15PENPENUMBRA1.87%$60.62M
16GKOSGLAUKOS1.57%$50.93M
17PODDINSULET1.42%$46.07M
18GMEDGLOBUS MEDICAL CLASS A1.26%$40.72M
19TFXTELEFLEX0.90%$28.98M
20LIVNLIVANOVA PLC0.65%$20.92M
21NVSTENVISTA HOLDINGS0.64%$20.74M
22ITGRINTEGER HOLDINGS CORP0.64%$20.63M
23IRTCIRHYTHM HOLDINGS INC0.58%$18.96M
24TMDXTRANSMEDICS GROUP0.45%$14.42M
25ATRCATRICURE0.40%$12.98M

IHI Expense Ratio

IHI charges 0.37% a year, about $37.00 for every $10,000 invested.

Yearly cost by amount invested
InvestedCost a year
$10,000$37.00
$25,000$92.50
$100,000$370.00

The fee is taken from the fund's assets rather than billed, so it shows up as slightly lower returns.

ETF Analytics Snapshot

Current ETF evidence uses fund profile, cost, size, distribution, momentum, and risk fields.

Price
$54.59
As of Oct 30, 2026
Fund size
$3.66B
Expense ratio
0.37%
Distribution yield
0.48%
IShares ETF evidence

ETF pages use fund-native profile fields for cost, size, liquidity, holdings breadth, NAV, issuer, and launch date.

Review ETF analytics
Holdings
49
NAV
$55.71
Average volume
2.86M
Inception
May 1, 2006
Asset class
Equity
Primary exposure
Health Care Equipment (99.81%)
Beta
0.83
Momentum score
79/100

ETF Fundamentals Overview

Fund-native evidence replaces stock-only quarterly statement fields for ETF pages.

Fund profile

FieldValue
Fund nameiShares U.S. Medical Devices ETF
IssuerIShares
Asset classEquity
Primary exposureHealth Care Equipment (99.81%)
DomicileUS
Inception dateMay 1, 2006
Websitehttps://www.ishares.com/us/products/239516/ishares-u-s-medical-devices-etf

Current ETF metrics

FieldValue
Fund size$3.66B
Expense ratio0.37%
Holdings count49
NAV$55.71
Average volume2.86M
Distribution yield0.48%
Beta0.83

ETF Exposure

Sector and country weights of the fund's holdings.

Sector exposure
FieldValue
Health Care Equipment99.81%
Cash and/or Derivatives0.19%
Country exposure
FieldValue
United States100.00%

ETF Risk-Adjusted Context

Risk and return-efficiency metrics sit beside fund structure rather than company financial statements.

AIQ Score
57/100

Composite research read.

Sharpe Ratio
-0.54

Return per unit of total volatility.

Sortino Ratio
—

Return per unit of downside volatility.

Max Drawdown
-26.24%

Largest trailing drawdown in the risk window.

Momentum
79/100

Trend and price behavior.

Value Exposure
31/100

Relative valuation/exposure context.

Risk
70/100

Volatility and downside resilience.

Annual Volatility
20.56%

Annualized realized volatility.

ETF analytics context
How to read IHI's ETF profile

Read cost, fund size, liquidity, holdings breadth, NAV, distribution yield, and exposure together. ETF analytics should not be judged by company-only fields such as revenue, EPS, margins, or payout ratio when those rows are not applicable.

Analysis tools

Export and portfolio tools complement the ETF evidence above.

Fundamentals export

Current evidence CSV · Pro workflow

Unlock with Pro
Portfolio context

Holding, weight, concentration · Personalized to holdings

Unlock with Premium
Continue to IHI AIQ Pro
See how ETF evidence contributes to the full analysis workspace.

How to Read a Fundamental Profile

Fundamental analysis is the discipline of estimating what a business is worth by examining the financial evidence it produces: how much it earns, how efficiently it converts revenue to cash, how much capital it uses to produce those earnings, and whether the current price compensates an investor for the risks of holding it. The metrics on this page are organized into six evidence buckets -- valuation, profitability, leverage, growth, efficiency, and company size -- because each bucket answers a different question. Valuation multiples answer whether the market price is cheap or expensive relative to underlying earnings power. Profitability answers whether the business model is inherently strong or thin. Leverage answers whether the balance sheet is durable under stress. No single ratio tells a complete story; the analysis is about how the full set hangs together.

The single most diagnostic question in fundamental analysis is whether a business generates returns on invested capital above its cost of capital. A business that earns 20% ROIC while its cost of capital is 9% is compounding value for shareholders at an 11-point spread -- and the market will typically pay a meaningful premium to book value for that privilege. A business that earns 8% ROIC against a 10% cost of capital is destroying economic value even if reported earnings are growing, because growth at below-cost returns dilutes per-share value rather than building it. This is why ROIC and gross margin -- which measures the inherent advantage in the product before overhead -- are the highest-signal fundamental metrics for evaluating business quality at the model level.

Valuation multiples (P/E, EV/EBITDA, P/S, P/FCF) measure what the market currently demands per unit of earnings, sales, or cash flow. They are not independently actionable: a low P/E can indicate value or distress, and a high P/E can indicate genuine quality or speculative excess. The interpretive work is contextual -- comparing a multiple to sector peers, to the company's own history, and to the underlying growth rate. The PEG ratio (P/E divided by earnings growth rate) is a simple first-order adjustment; EV/EBITDA is more reliable for cross-capital-structure comparisons because it normalizes for debt. FCF yield (FCF / market cap) is the cleanest single valuation signal for mature businesses because it is harder to manipulate than GAAP earnings.

Growth metrics deserve careful handling. Revenue growth that outpaces earnings growth signals margin compression -- revenue expansion without profitability improvement. EPS growth that outpaces revenue growth often reflects share buybacks rather than operational leverage, which is worth distinguishing. The highest-quality growth signature is expanding ROIC alongside revenue growth: the business is finding new markets without sacrificing the economics that made the existing business attractive. Declining ROIC with accelerating revenue growth is the opposite -- scale without economics, often the precursor to a valuation reset.

How to Read This Table

  • Valuation multiples (P/E, EV/EBITDA): Compare within sector and against the company's own 5-year history before concluding cheap or expensive.
  • ROIC vs WACC spread: The most important single quality signal. Sustained ROIC above cost of capital is the foundation of durable long-term returns.
  • Gross margin: Measures inherent product economics before overhead. Declining gross margin at scale is an early warning sign.
  • Debt-to-Equity and Interest Coverage: Frame balance sheet durability. Interest coverage below 3x reduces resilience in stress.
  • FCF yield: Divide trailing free cash flow by market cap. Yields above 4-5% are generally constructive; negative FCF yield requires a clear path to conversion.
  • Revenue growth vs. EPS growth: The gap between them tells you whether scale is creating or consuming margin.

These are analytical tools, not investment recommendations. Historical patterns do not guarantee future results.

IHI ETF Analytics FAQ

What is IHI's expense ratio?

IHI's expense ratio shows the annual fund cost when available. Compare it with holdings, tracking exposure, liquidity, dividend yield, and volatility.

What is IHI's dividend yield?

IHI's dividend or distribution yield helps investors compare income potential. It should be weighed against fund strategy, expense ratio, and risk.

How diversified is IHI?

IHI's diversification depends on holdings count, top-position concentration, and sector exposure. Fund size and liquidity do not automatically mean broad diversification.

Is IHI overvalued or undervalued?

ETF valuation depends on the valuation of its underlying holdings, sector exposure, and market regime. Use fund fundamentals with risk and technical context.